RDEA3170, 5 mg: Clinical Trials

1 trial of RDEA3170, 5 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow RDEA3170, 5 mg: new trials by email Literature Review of RDEA3170, 5 mg trials Research Report on RDEA3170, 5 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RDEA3170 Tablet and Capsule Bioavailability Study
RDEA3170,10 mg, RDEA3170, 2.5 mg, RDEA3170, 5 mg - Healthy
Phase 1CompletedArdea Biosciences, Inc.352015-05-012018-08-20

Sponsors

Ardea Biosciences, Inc. (1)

Countries

United States (1)

Top investigators

J Hall, MD (1)